Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 83 Records) |
| Query Trace: Fibrosis and TM6SF2[original query] |
|---|
Common genetic variation in alcohol-related hepatocellular carcinoma: a case-control genome-wide association study.
The Lancet. Oncology 2021 12 23 (1): 161-171. Trépo Eric, Caruso Stefano, Yang Jie, Imbeaud Sandrine, Couchy Gabrielle, Bayard Quentin, Letouzé Eric, Ganne-Carrié Nathalie, Moreno Christophe, Oussalah Abderrahim, Féray Cyrille, Blanc Jean Frédéric, Clément Bruno, Hillon Patrick, Boursier Jérôme, Paradis Valérie, Calderaro Julien, Gnemmi Viviane, Nault Jean-Charles, Guéant Jean-Louis, Devière Jacques, Archambeaud Isabelle, Vitellius Carole, Turlin Bruno, Bronowicki Jean-Pierre, Gustot Thierry, Sutton Angela, , Ziol Marianne, Nahon Pierre, Zucman-Rossi Jessi |
| Genetic Polymorphisms and Clinical Features in Diabetic Patients With Fatty Liver: Results From a Single-Center Experience in Southern Italy. Frontiers in medicine 2021 8 737759. Villani Rosanna, Magnati Grazia Pia, De Girolamo Giuseppe, Sangineto Moris, Romano Antonino Davide, Cassano Tommaso, Serviddio Gaeta |
| Low Lipoprotein(a) Levels Predict Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. Hepatology communications 2021 10 6 (3): 535-549. Meroni Marica, Longo Miriam, Lombardi Rosa, Paolini Erika, Macchi Chiara, Corsini Alberto, Sirtori Cesare R, Fracanzani Anna Ludovica, Ruscica Massimiliano, Dongiovanni Pao |
| Quantitative modeling of human liver reveals dysregulation of glycosphingolipid pathways in nonalcoholic fatty liver disease. iScience 2022 9 25 (9): 104949. Sen Partho, Govaere Olivier, Sinioja Tim, McGlinchey Aidan, Geng Dawei, Ratziu Vlad, Bugianesi Elisabetta, Schattenberg Jörn M, Vidal-Puig Antonio, Allison Michael, Cockell Simon, Daly Ann K, Hyötyläinen Tuulia, Anstee Quentin M, Oreši? Mat |
| Effect of common genetic variants on the risk of cirrhosis in non-alcoholic fatty liver disease during 20?years of follow-up. Liver international : official journal of the International Association for the Study of the Liver 2022 9 42 (12): 2769-2780. Holmer Magnus, Ekstedt Mattias, Nasr Patrik, Zenlander Robin, Wester Axel, Tavaglione Federica, Romeo Stefano, Kechagias Stergios, Stål Per, Hagström Hann |
| Genetic variants associated with steatohepatitis and liver fibrosis in HIV-infected patients with NAFLD. Frontiers in pharmacology 2022 13 905126. Busca C, Arias P, Sánchez-Conde M, Rico M, Montejano R, Martín-Carbonero L, Valencia E, Moreno V, Bernardino J I, Olveira A, Abadía M, González-García J, Montes M |
| PNPLA3 and TM6SF2 genetic variants and hepatic fibrosis and cirrhosis in Pakistani chronic hepatitis C patients: a genetic association study. BMC gastroenterology 2022 Aug 22 (1): 401. Rauff Bisma, Alzahrani Badr, Chudhary Shafiq A, Nasir Bilal, Mahmood Saqib, Bhinder Munir Ahmad, Faheem Muhammad, Amar A |
| Improvement of liver fibrosis, but not steatosis, after HCV eradication as assessment by MR-based imaging: Role of metabolic derangement and host genetic variants. PloS one 2022 17 (6): e0269641. Chuaypen Natthaya, Siripongsakun Surachate, Hiranrat Pantajaree, Tanpowpong Natthaporn, Avihingsanon Anchalee, Tangkijvanich Pis |
| Influence of Type 2 Diabetes in the Association of PNPLA3 rs738409 and TM6SF2 rs58542926 Polymorphisms in NASH Advanced Liver Fibrosis. Biomedicines 2022 Apr 10 (5): . Gabriel-Medina Pablo, Ferrer-Costa Roser, Rodriguez-Frias Francisco, Ciudin Andreea, Augustin Salvador, Rivera-Esteban Jesus, Pericàs Juan M, Selva David Martin |
| Nonalcoholic fatty liver disease risk and histologic severity are associated with genetic polymorphisms in children. Hepatology (Baltimore, Md.) 2022 5 77 (1): 197-212. Goyal Nidhi P, Rosenthal Sara B, Nasamran Chanod, Behling Cynthia A, Angeles Jorge E, Fishbein Mark H, Harlow Kathryn E, Jain Ajay K, Molleston Jean P, Newton Kimberly P, Ugalde-Nicalo Patricia, Xanthankos Stavra A, Yates Katherine, Schork Nicholas J, Fisch Kathleen M, Schwimmer Jeffrey B, |
| Evaluation of the association of a variant in PNPLA3 and TM6SF2 with fibrosis progression in patients with chronic hepatitis C infection after eradication: A retrospective study. Gene 2022 Feb 820 146235. Kang Qian, Xu Jinghang, Luo Hao, Tan Ning, Chen Hongyu, Cheng Ran, Pan Jiali, Han Yifan, Yang Yuqing, Liu Dan, Xi Hongli, Yu Min, Xu Xiaoyu |
| MTARC1 and HSD17B13 Variants Have Protective Effects on Non-Alcoholic Fatty Liver Disease in Patients Undergoing Bariatric Surgery. International journal of molecular sciences 2022 12 23 (24): . Kalinowski Piotr, Smyk Wiktor, Nowosad Ma?gorzata, Paluszkiewicz Rafa?, Micha?owski ?ukasz, Ziarkiewicz-Wróblewska Bogna, Weber Susanne N, Milkiewicz Piotr, Lammert Frank, Zieniewicz Krzysztof, Krawczyk Marc |
| Different effects of low muscle mass on the risk of non-alcoholic fatty liver disease and hepatic fibrosis in a prospective cohort. Journal of cachexia, sarcopenia and muscle 2022 11 14 (1): 260-269. Choe Hun Jee, Lee Hyunsuk, Lee DongHo, Kwak Soo-Heon, Koo Bo Kyu |
| TM6SF2 rs58542926 is related to hepatic steatosis, fibrosis and serum lipids both in adults and children: A meta-analysis. Frontiers in endocrinology 2022 11 13 1026901. Li Xue-Ying, Liu Zheng, Li Li, Wang Hai-Jun, Wang H |
| Influence of the Bile Acid Transporter Genes ABCB4, ABCB8, and ABCB11 and the Farnesoid X Receptor on the Response to Ursodeoxycholic Acid in Patients with Nonalcoholic Steatohepatitis. Journal of personalized medicine 2023 7 13 (7): . Henriette Kreimeyer, Katharina Vogt, Tobias Götze, Jan Best, Oliver Götze, Jochen Weigt, Alisan Kahraman, Mustafa Özçürümez, Julia Kälsch, Wing-Kin Syn, Svenja Sydor, Ali Canbay, Paul Man |
| Characteristics and long-term mortality of patients with non-MAFLD hepatic steatosis. Hepatology international 2023 3 . Fan Hong, Liu Zhenqiu, Zhang Pengyan, Wu Sheng, Han Xinyu, Huang Yiwen, Zhu Yichen, Chen Xingdong, Zhang Tiej |
| Genetic Variants Determine Treatment Response in Autoimmune Hepatitis. Journal of personalized medicine 2023 3 13 (3): . Zandanell Stephan, Balcar Lorenz, Semmler Georg, Schirmer Alex, Leitner Isabella, Rosenstatter Lea, Niederseer David, Sotlar Karl, Schneider Anna-Maria, Strasser Michael, Gensluckner Sophie, Feldman Alexandra, Datz Christian, Aigner Elm |
| Parental History of Type 2 Diabetes Mellitus and PNPLA3 Polymorphism Increase the Risk of Severe Stages of Nonalcoholic Fatty Liver Disease. Digestive diseases and sciences 2023 12 . Natalia Balassiano Wajsbrot, Nathalie Carvalho Leite, Paulo Henrique Condeixa Franca, Claudia Regina Lopes Cardoso, Gil Fernando Salles, Cristiane A Villela-Noguei |
| Associations between metabolic hyperferritinaemia, fibrosis-promoting alleles and clinical outcomes in steatotic liver disease. Liver international : official journal of the International Association for the Study of the Liver 2023 11 . Deepika Suresh, Ashley Li, Matthew J Miller, Karn Wijarnpreecha, Vincent L Ch |
| The impact of genetic risk on the prevalence of advanced fibrosis and cirrhosis in prospectively assessed patients with type 2 diabetes. Alimentary pharmacology & therapeutics 2024 6 . Lana Bridi, Saaket Agrawal, Kaleb Tesfai, Egbert Madamba, Ricki Bettencourt, Lisa M Richards, Amit V Khera, Rohit Loomba, Veeral Ajme |
| Use of PNPLA3, TM6SF2, and HSD17B13 for detection of fibrosis in MASLD in the general population. Clinics and research in hepatology and gastroenterology 2024 6 48 (7): 102389. Elias Badal Rashu, Mikkel Parsberg Werge, Liv Eline Hetland, Mira Thing, Puria Nabilou, Nina Kimer, Anders Ellekaer Junker, Anne-Sofie Houlberg Jensen, Børge Grønne Nordestgaard, Stefan Stender, Lise Lotte Glu |
| Distinct Gut Microbial Signature and Host Genetic Variants in Association with Liver Fibrosis Severity in Patients with MASLD. Nutrients 2024 6 16 (12): . Nantawat Satthawiwat, Thananya Jinato, Sawannee Sutheeworapong, Natthaporn Tanpowpong, Natthaya Chuaypen, Pisit Tangkijvani |
| Are transmembrane 6 superfamily member 2 gene polymorphisms associated with steatohepatitis after pancreaticoduodenectomy? JGH open : an open access journal of gastroenterology and hepatology 2024 6 8 (6): e13113. Tomotaka Mori, Eisuke Ozawa, Ryu Sasaki, Akane Shimakura, Kosuke Takahashi, Yoko Kido, Yasuko Kanda, Satoshi Matsuo, Kazuaki Tajima, Asami Beppu, Yasuhiko Nakao, Masanori Fukushima, Masafumi Haraguchi, Satoshi Miuma, Hisamitsu Miyaaki, Tomohiko Adachi, Susumu Eguchi, Shinji Okano, Kazuhiko Nak |
| Liver fibrosis assessed via non-invasive tests is associated with incident heart failure in a general population cohort. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2024 5 . Theresa J Hydes, Oliver J Kennedy, Kate Glyn-Owen, Ryan Buchanan, Julie Parkes, Daniel J Cuthbertson, Paul Roderick, Christopher D Byr |
| Genetic risk accentuates dietary effects on hepatic steatosis, inflammation and fibrosis in a population-based cohort. Journal of hepatology 2024 4 . Vincent L Chen, Xiaomeng Du, Antonino Oliveri, Yanhua Chen, Annapurna Kuppa, Brian D Halligan, Michael A Province, Elizabeth K Speliot |
| Relevance of PNPLA3, TM6SF2, HSD17B13, and GCKR Variants to MASLD Severity in an Egyptian Population. Genes 2024 4 15 (4): . Nehal Elmansoury, Ahmed A Megahed, Ahmed Kamal, Nefertiti El-Nikhely, Marina Labane, Manal Abdelmageed, Ann K Daly, Ahmed Wah |
| Differential effects of genetic polymorphism on comorbid disease in metabolic dysfunction-associated steatotic liver disease. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2024 4 . Yuya Seko, Kanji Yamaguchi, Toshihide Shima, Michihiro Iwaki, Hirokazu Takahashi, Miwa Kawanaka, Saiyu Tanaka, Yasuhide Mitsumoto, Masato Yoneda, Atsushi Nakajima, Takeshi Okanoue, Yoshito It |
| Type 2 diabetes and the minor allele of PNPLA3 consistently identify high-risk metabolic dysfunction associated steatotic liver disease. Diabetes research and clinical practice 2024 12 219 111960. Zobair M Younossi, J Michael Estep, Sean Felix, Brian Lam, Zaid Younossi, Andrei Racila, Maria Stepano |
| Clinical Utility of Genetic Variants in PNPLA3 and TM6SF2 to Predict Liver-Related Events in Metabolic Dysfunction-Associated Steatotic Liver Disease. Liver international : official journal of the International Association for the Study of the Liver 2024 10 . Yuya Seko, Kanji Yamaguchi, Toshihide Shima, Michihiro Iwaki, Hirokazu Takahashi, Miwa Kawanaka, Saiyu Tanaka, Yasuhide Mitsumoto, Masato Yoneda, Atsushi Nakajima, Takeshi Okanoue, Yoshito It |
| TM6SF2-rs58542926 genotype has opposing effects on incidence of hepatic and cardiac events in a community cohort: TM6SF2 effects on liver and cardiac outcomes. The American journal of gastroenterology 2024 10 . Vincent L Chen, Antonino Oliveri, Chinmay Raut, Yanhua Chen, Kelly C Cushing-Damm, Elizabeth K Speliot |
- Page last reviewed:Feb 1, 2024
- Content source: